Reply to: "Errors in modeling misrepresent the utility of the enhanced liver fibrosis test in the management of non-alcoholic fatty liver disease"
- PMID: 32951911
- DOI: 10.1016/j.jhep.2020.08.007
Reply to: "Errors in modeling misrepresent the utility of the enhanced liver fibrosis test in the management of non-alcoholic fatty liver disease"
Conflict of interest statement
Conflict of interest QMA is coordinator of the IMI2 LITMUS consortium. The other authors declare no conflicts of interest that pertain to this work. Please refer to the accompanying ICMJE disclosure forms of the original study for further details.
Comment on
-
Enhanced liver fibrosis test for the non-invasive diagnosis of fibrosis in patients with NAFLD: A systematic review and meta-analysis.J Hepatol. 2020 Aug;73(2):252-262. doi: 10.1016/j.jhep.2020.03.036. Epub 2020 Apr 8. J Hepatol. 2020. PMID: 32275982
-
Errors in modeling misrepresent the utility of the enhanced liver fibrosis test in the management of non-alcoholic fatty liver disease.J Hepatol. 2020 Dec;73(6):1580-1581. doi: 10.1016/j.jhep.2020.07.009. Epub 2020 Sep 28. J Hepatol. 2020. PMID: 32994080 No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
